France launches massive virus surveillance in GP clinics
NCT ID NCT07599449
First seen May 21, 2026 · Last updated Jun 22, 2026 · Updated 1 time
Summary
This study will track common respiratory viruses like flu, COVID-19, and RSV in up to 25,000 people visiting their doctor in France. Doctors will collect saliva or nose swabs from patients with cold or flu symptoms to see which viruses are spreading. The goal is to better understand virus circulation and help public health officials respond to outbreaks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IPLESP - UMR S 1136, N° BC 2908, Faculté de médecine Sorbonne Université, site Saint Antoine, 27 rue Chaligny
Paris, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this surveillance could improve understanding of which respiratory viruses are circulating and help guide vaccination strategies and public health measures.
What could go wrong
This is an observational study, not a treatment trial. It won't directly benefit participants and may face challenges in sample collection or data completeness.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.